| Papillary Adenocarcinoma studied in …STUDIED_INderived200 of 200show fewer |
|---|
| → studied in | NCT04071223Phase 2 · active not recruiting Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07024680completed Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05575440terminated Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03635892Phase 2 · active not recruiting A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04544111Phase 2 · active not recruiting PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07140757recruiting Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07823439not yet recruiting Pattern and Surgical Outcome of Papillary Thyroid Cancer at Sohag University Hospitals · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101775Phase 2 · active not recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Primary Peritoneal Serous Papillary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05411081Phase 2 · active not recruiting Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981509Phase 2 · recruiting Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001160recruiting Studies on Tumors of the Thyroid · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02152995Phase 2 · active not recruiting Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568267Phase 2 · active not recruiting Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781137recruiting Analysis of Long-term Outcomes of Endoscopic Resection of Duodenal and Ampullary Mucosal and Submucosal Lesions · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06792552Phase 1 · recruiting A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07440290Phase 2/Phase 3 · recruiting DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978625Phase 2 · active not recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07652450NA · completed Incidental Thyroid Cancer in Cases With Inflammatory Thyroid Lesion · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04623801Phase 2 · active not recruiting Laser Ablation of Papillary Thyroid Microcarcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Microcarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914300Phase 2 · active not recruiting Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Follicular Variant Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05665361Phase 1/Phase 2 · recruiting Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04413123Phase 2 · active not recruiting Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03541902Phase 2 · active not recruiting Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07521670Phase 2 · not yet recruiting Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP) · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01116648Phase 1/Phase 2 · active not recruiting Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Primary Peritoneal Serous Papillary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07302672NA · recruiting Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07695974completed Clinicopathological Predictors of Recurrence in Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07545837NA · recruiting Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06339138completed Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06959641Phase 2 · recruiting XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07529080NA · not yet recruiting Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07659717completed Frozen Section-Guided Selective Ipsilateral Central Neck Dissection in Bethesda V-VI Thyroid Nodules · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Nasopharyngeal Low Grade Papillary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07506161completed Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Microcarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07630363Phase 1/Phase 2 · not yet recruiting PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07584447not yet recruiting Clinical Utility of Preoperative Thyroid GuidePx® Testing · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05043090Phase 3 · active not recruiting Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04759911Phase 2 · active not recruiting Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07376837NA · recruiting Radiofrequency Ablation for Curative Treatment of Small Low-Risk Papillary Thyroid Cancer: Pilot Study · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00898365completed Study of Kidney Tumors in Younger Patients · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02609685NA · recruiting Active Surveillance of Papillary Thyroid Microcarcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Microcarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730321recruiting Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS) · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06899347NA · not yet recruiting The Role of Prophylactic Central Compartment Neck Dissection in the Management of 2 to 4 cm Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07536412NA · not yet recruiting Decision Aid Efficacy in Low Risk Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Microcarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04948437active not recruiting Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06316895recruiting The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03753919Phase 2 · terminated Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05122546Phase 1 · active not recruiting CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07243067not yet recruiting Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07391514completed Deep Learning-Based Intraoperative Dual-tracer Video Analysis of Sentinel Lymph Node Mapping for Metastasis Prediction in cN0 Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06235814NA · completed Molecular Analysis for Precision Surgery in Thyroid Cancer Trial · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06440850Phase 2 · recruiting Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04623502NA · recruiting An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05014698NA · terminated IDEntification of New Predisposition Genes in Differentiated THYroid Cancer · condition mapped PROBABILISTIC · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07357571recruiting Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07354698Phase 4 · not yet recruiting Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06133374recruiting Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899792Phase 1/Phase 2 · active not recruiting A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07314255active not recruiting The Role of Trop2 in Radioactive Iodine-131 Therapy Sensitivity in Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07299318not yet recruiting Multimodal Deep Learning for Lymph Node Metastasis in Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06623578NA · recruiting Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04624477active not recruiting Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05768178Phase 2/Phase 3 · recruiting DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05024929recruiting Targeted Therapy to Increase RAI Uptake in Metastatic DTC · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985604Phase 2 · terminated Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07167329Phase 2 · recruiting Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Endolymphatic Sac Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04462471Phase 1 · completed Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06439745completed More Than 50% of Unifocal cN0 T1b/Small T2 Papillary Thyroid Carcinoma May Require Completion Thyroidectomy if Nodal Status is Evaluated · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02973997Phase 2 · completed Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Columnar Cell Variant Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01723202Phase 2 · completed Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05752669completed Oxidative Stress and Mitochondrial TERT in Papillary Thyroid Cancer. · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07107503completed 10 Years' Follow-up Results of Ultrasound-guided Radiofrequency Ablation Versus Surgery for Low-risk Papillary Thyroid Micro-carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Microcarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04197960NA · completed Microwave Ablation and Surgical Resection for Micropapillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07066644completed Intraoperative Pathologic Evaluation of Central Lymph Nodes in Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07062211active not recruiting Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin Level · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07042984not yet recruiting RET-US Study - Ultrasound-Based Prediction of RET Alterations and Lateral-Neck Metastasis in Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03469011Phase 1 · terminated A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer. · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03037385Phase 1/Phase 2 · completed Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04129411NA · completed Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06254859recruiting Intraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid Surgery · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06971965NA · not yet recruiting Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients. · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06261190enrolling by invitation Active Surveillance for Low-risk Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730893NA · not yet recruiting Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05003856NA · terminated Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05410821Phase 1 · completed Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381641Phase 2 · completed Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01767636Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06733740recruiting Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05132205NA · completed Radiofrequency Ablation of Papillary Thyroid Microcarcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06800482NA · recruiting A Study of Online Follow-up in Patients With Papillary Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06791005Phase 3 · recruiting A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer. · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03906331approved for marketing Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02761057Phase 2 · completed Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06725576recruiting Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04731467Phase 1/Phase 2 · completed A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05500508Phase 1/Phase 2 · terminated Oral AMXT 1501 Dicaprate in Combination With IV DFMO · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05668962Phase 2 · recruiting Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06725628not yet recruiting Multiomics Study of Biological Behavior of Lymph Node Metastasis in Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05263141NA · completed Retro-Auricular Single-Site Endoscopic to Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05760690NA · completed Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05424692NA · recruiting Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05620134Phase 1/Phase 2 · active not recruiting Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05766098recruiting Definition of Mutational Profile of Papillary Thyroid Tumors by Mass-ARRAY · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06626581not yet recruiting Iodine Status and Characteristics of Papillary Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06592755recruiting Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for PTC · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06583057completed Multicenter Comparison of Thermal Ablation Versus Thyroid Lobectomy for Subcapsular Papillary Thyroid Microcarcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Microcarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02393690Phase 2 · completed Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06468696NA · unknown Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399159completed Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological Images · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03470259Phase 1 · completed Precision Thyroid Cancer Surgery With Molecular Fluorescent Guided Imaging · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06333587recruiting Minimally Invasive Treatments of the Thyroid · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Microcarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06325787NA · completed Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04354324NA · unknown Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06286631recruiting Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New Scale · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06271044NA · active not recruiting a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05962892recruiting A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06146777Phase 3 · not yet recruiting Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05545852NA · unknown A Clinical Study of Transaxillary Endoscopic and Open Thyroidectomy for PTC · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06068101completed Clinical and Genetic Investigation of the Association Between Primary Aldosteronism and Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01659385completed Leptin Levels in Papillary Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644315Phase 2 · terminated A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02814032unknown Proteomics of Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05932121unknown Cross-sectional Case and Control Study on Quality of Life, Appearance and Functions in PTC Via Different Surgical Approach · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05873283completed Papillary Thyroid Cancer and Central Lymp Node Dissection · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04603365Phase 2 · withdrawn Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Hereditary Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05796960unknown European Multicenter Study on Surgical Management of Advanced Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03506048Phase 2 · terminated Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03432299NA · unknown Radiofrequency Ablation of Low Risk Papillary Thyroid Microcarcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Microcarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02489695Phase 2 · completed Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470496Phase 1 · completed Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02418390NA · completed The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02938702active not recruiting Active Surveillance on Papillary Thyroid Microcarcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Microcarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05247476Phase 4 · unknown Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients. · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05191927completed A Nomogram Model to Predict Central Lymphnode Metastasis in Thyroid Papillary Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02178345completed Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01208051Phase 1/Phase 2 · completed Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03630120Phase 2 · terminated Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02127710Phase 2 · completed A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC) · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02138214Phase 2 · completed Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04664413unknown Percentage of BRAFV600E Alleles and Outcome in Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02283658Phase 2 · completed Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Primary Peritoneal Serous Papillary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04594720completed Circulating Biomarkers to Identify Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01441154completed Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00668811Phase 2 · completed Sutent Adjunctive Treatment of Differentiated Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04500925completed The Incidence of Postoperative Re-stratification for Recurrence in Well-differentiated Thyroid Cancer - A Single Tertiary Israeli Center Experience · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04076514unknown The Role of Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04424485NA · unknown Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02837991Phase 1 · terminated A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04411290unknown Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04396912unknown Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04336696NA · unknown Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0? · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00078858Phase 1/Phase 2 · completed Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Type 1 Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027820Phase 1/Phase 2 · completed Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Type 1 Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01974284NA · terminated Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02768753NA · completed Comparison Between the Axillary Bilateral-breast Approach (ABBA) and Bilateral Axillo-breast Approach (BABA) for Robotic Thyroidectomy · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005799NA · completed Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Type 1 Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03889769unknown Evaluation of Accuracy of One-Step Nucleic Acid Amplification (OSNA) in Diagnosis of Lymph Node Metastases of Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01010126Phase 2 · completed Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Primary Peritoneal Serous Papillary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01688973Phase 2 · completed Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Type 1 Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104871Phase 2 · completed Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085293Phase 2 · completed Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131 · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03411187NA · unknown Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03454477NA · unknown Comparison Between Robotic, Endoscopic and Traditional Open Surgery in Thyroidectomy · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01727089Phase 2 · completed Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Type 1 Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03623516completed Overdiagnosis of Thyroid Cancer in the Marne and Ardennes Departments of France From 1975 to 2014 · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01502410Phase 2 · completed Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01811212Phase 2 · completed Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03359668NA · completed CT Detection of Metastatic Lymphadenopathy in Papillary Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00335556Phase 2 · completed Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02561533NA · completed Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01754519Phase 2 · terminated Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Breast Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01392222completed Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Microcarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02442661completed Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01927887NA · completed Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00519896Phase 2 · completed Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00729157Phase 2 · completed Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01534897NA · completed Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436 · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118248Phase 2 · completed Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00559949Phase 2 · completed Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02952612unknown Active Surveillance of Papillary Thyroid Microcarcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02323724completed APPLICATION OF MOLECULAR TECHNIQUES FOR IMPROVING THE DIAGNOSIS AND TREATMENT OF NODULAR THYROID LESIONS. · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02648399NA · unknown Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01413113Phase 1 · completed Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053235withdrawn Research Study in Patients With Advanced Ovarian Epithelial Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Primary Peritoneal Serous Papillary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01311089completed A Comparative Study of Robotic Thyroidectomy Using Transaxillary Approach Versus Conventional Open Thyroidectomy · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126503Phase 1/Phase 2 · completed Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00134043Phase 2 · completed Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098813Phase 2 · completed Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02140476NA · unknown Comparative Analysis Between Bipolar Device and Conventional Tie & Suture Technique in Thyroidectomy · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01354639completed Comparative Study of Surgical Completeness After Robotic Thyroidectomy Versus Conventional Open Thyroidectomy · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095693Phase 2 · terminated Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01100619Phase 1 · completed A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098618Phase 2 · terminated Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 200 trials mapped (77 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068497NA · completed Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01510002NA · completed Prophylactic Central Neck Dissection for Papillary Thyroid Cancer · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00451880Phase 1 · completed Study of XL281 in Adults With Solid Tumors · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01417442early Phase 1 · unknown BRAF V600E Mutations In Papillary Thyroid Carcinoma · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00984191NA · unknown Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid · condition mapped ALIAS · 200 trials mapped (77 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |